Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study

N. Bergmann, M. Foerster, A. Reissig, C. Kroegel (Jena, Germany)

Source: Annual Congress 2006 - Established and experimental therapies for allergic asthma
Session: Established and experimental therapies for allergic asthma
Session type: Thematic Poster Session
Number: 2557
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Bergmann, M. Foerster, A. Reissig, C. Kroegel (Jena, Germany). Benefits of interferon-αcon-1 (IFN-αcon-1) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy. Results of a 12-month prospective case-controlled study. Eur Respir J 2006; 28: Suppl. 50, 2557

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA)
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019


Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study
Source: ERJ Open Res, 5 (1) 00175-2018; 10.1183/23120541.00175-2018
Year: 2019



Evaluation of ICS/LABA combination therapy on respiratory function in patients with asthma: Open-label, randomized, cross-over trial.
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018


Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX)
Source: International Congress 2018 – Paediatric asthma: prevention, diagnosis and treatment
Year: 2018




Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study
Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020
Year: 2021



Home rehabilitation in COPD patients on long term oxygen therapy (LTOT) : a multi-centre randomized controlled study
Source: Eur Respir J 2002; 20: Suppl. 38, 233s
Year: 2002

Metabolomic approach in the characterization of omalizumab responders and non-responders among children with severe asthma: a multicenter prospective study.
Source: Virtual Congress 2021 – Advances in childhood asthma: biologics, biomarkers and infections
Year: 2021



Safety and benefit of adjunctive systemic corticosteroid therapy in the management of severe, smear positive pulmonary tuberculosis (SSP-PTB); an interim analysis of a randomized controlled trial
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012


The patterns of inadequate drug administration in children with asthma: a multi-center retrospective study
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002

Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


Stop omalizumab: a multicenter follow up study after discontinuation in pediatric patients with severe asthma
Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches
Year: 2021


Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial
Source: Eur Respir J 2001; 17: 206-213
Year: 2001



A multicenter randomized trial for the effectiveness of structured discharge and follow-up protocol on readmission rate in COPD patients receiving LTOT/NIV: one-year interim analysis.
Source: International Congress 2018 – Hot topics in non-invasive ventilation
Year: 2018



Multidimensional assessment and targeted therapy of severe asthma: a randomised controlled trial (RCT)
Source: International Congress 2017 – Many faces of asthma assessment
Year: 2017



Home care combining oral nutritional supplement, exercise and androgen substitution in malnourished patients with chronic respiratory failure: a prospective controlled randomized multicenter trial
Source: Annual Congress 2008 - Integrated care and long-term strategies
Year: 2008

“Stepping down” in mild-to-moderate asthmatic children being well controlled while receiving low doses of inhaled corticosteroids (ICS): Daily vs. cyclical ICS administration (prospective, randomized, multicentre, open-label trial)
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013


What predicts poor collection of medication among children with asthma? A case-control study
Source: Eur Respir J 2002; 20: 1464-1469
Year: 2002



Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial
Source: Eur Respir J, 49 (6) 1700561; 10.1183/13993003.00561-2017
Year: 2017



Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021